{"id":510939,"date":"2021-07-08T09:03:47","date_gmt":"2021-07-08T13:03:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers-researchers-and-patients-2\/"},"modified":"2021-07-08T09:03:47","modified_gmt":"2021-07-08T13:03:47","slug":"philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers-researchers-and-patients-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers-researchers-and-patients-2\/","title":{"rendered":"Philips and Cognizant Collaborate to Introduce Digital Health Solutions to Providers, Researchers and Patients"},"content":{"rendered":"
\n

Alliance Pairs Cloud-Based Healthcare Platform with Experience-Oriented Application Design to Improve Patient Care and Clinical Trials Through Increased Provider-Patient Connectivity<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n AMSTERDAM<\/span> and TEANECK, N.J.<\/span>, July 8, 2021<\/span> \/PRNewswire\/ —\u00a0Royal Philips<\/span><\/a>\u00a0(NYSE: PHG, AEX: PHIA), a global leader in health technology, and Cognizant<\/a>\u00a0(Nasdaq: CTSH), a world-leading professional services firm, today announced a new collaboration to develop end-to-end digital health solutions that will enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials. The strategic alliance brings together Philips HealthSuite, a cloud-based platform and Cognizant’s digital engineering expertise to deliver and maintain leading-edge digital health solutions at scale, providing advanced connectivity and using big data to create actionable insights. <\/p>\n

\n

\n
\n \"Cognizant
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Philips HealthSuite<\/a>,\u00a0built on Amazon Web Services, is an integrated, modular set of standards-based capabilities that support the development of digital health propositions. The platform securely stores critical healthcare data\u00a0and provides both\u00a0advanced data analytics and AI capabilities, while delivering industry-leading interoperability, connectivity, and regulatory compliance. To date,\u00a0more than 100 types of medical devices have been integrated into HealthSuite, with over 145 billion clinical images securely archived on the cloud platform. <\/p>\n

As part of this collaboration, Cognizant will build, deploy, implement, and operate client-specific applications on Philips HealthSuite. These customizable, scalable solutions integrate advanced data analytics, helping to improve\u00a0both\u00a0the patient and clinician experience by providing relevant data to the appropriate point-of-care. <\/p>\n

With these solutions, healthcare providers can monitor their patients outside traditional clinical settings, and patients can stay more informed of their own well-being. In addition,\u00a0both biopharmaceutical and medical device manufacturers can quickly gain actionable insights through advanced analytics to\u00a0make more informed\u00a0clinical development decisions and rapidly bring new solutions to patients. <\/p>\n

“Despite advances, patients and clinicians still face a fragmented technology and data landscape that holds back innovative healthcare services which improve care quality and the human experience,” said Shez Partovi<\/span>, Chief Innovation &\u00a0Strategy Officer, Royal Philips<\/span>. “Philips is committed to driving the digital transformation of healthcare. Partnering with Cognizant’s experienced digital engineering teams will accelerate the adoption of solutions built on Philips HealthSuite, delivering digital solutions across the healthcare continuum in a secure and compliant manner, and ultimately helping guide better health decisions for patients.”<\/p>\n

For Life Sciences companies, Philips HealthSuite’s compliant and secure medical device connectivity, data integration, and analysis will also benefit remote patient monitoring and decentralized clinical trials. This will enable a reduction in\u00a0paperwork, help\u00a0researchers reach more diverse trial participants, and improve\u00a0connectivity between investigators and participants \u2013 with the goal of improving the quality and speed of therapy development. <\/p>\n

“Cognizant and Philips are\u00a0each dedicated to improving people’s lives through health technology,” said Ursula Morgenstern<\/span>, President of Global Growth Markets at Cognizant. “This new collaboration will provide critical\u00a0solutions that help manage\u00a0the growing amount of health data\u00a0available, keep patients and providers better\u00a0connected,\u00a0and help accelerate\u00a0life-saving therapies to market. Virtual and digital health solutions are fundamental to improving health awareness and engagement. We\u00a0are proud to work with Philips, a world leader in healthtech, to support the health and well-being of people everywhere.”\u00a0<\/p>\n

\n Learn More:<\/b>\n <\/p>\n